Physician profile
Michael S Varon
NPI 1386662641
$564.10
in general payments reported to CMS, 2019-2025
10 companies · $73.82 in 2025
The $73.82 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.22 · 2022: $66.27 · 2023: $288 · 2024: $107 · 2025: $73.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $172.56 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $106.46 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $100.68 | 2021-2025 | Shingrix, Arexvy |
| Abbott Laboratories | $51.77 | 2023-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $27.33 | 2023 | Cologuard Collection Kit |
| Linus Health, INC. | $26.48 | 2023 | |
| Abbvie INC. | $24.61 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.17 | 2025 | |
| Pfizer INC. | $18.31 | 2023 | |
| Cranial Technologies, INC | $14.73 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Varon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.